HPV CANCERS

Clinical trials for HPV CANCERS explained in plain language.

Never miss a new study

Get alerted when new HPV CANCERS trials appear

Sign up with your email to follow new studies for HPV CANCERS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Completed 1

Triple immunotherapy attack shows promise against Hard-to-Treat HPV cancers

Disease control Completed

This study tests a combination of three immunotherapy drugs—PDS0101, M7824, and NHS-IL12—in people with advanced HPV-related cancers such as cervical, anal, and throat cancers. The goal is to see if the mix can shrink tumors or stop them from growing. Participants receive the dru…

Matched conditions: HPV CANCERS

Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Jul 02, 2026 00:00 UTC

HPV CANCERS

Get alerted when new HPV CANCERS trials appear

Triple immunotherapy attack shows promise against Hard-to-Treat HPV cancers